Docosahexaenoic acid exerts anti-inflammatory action on human eosinophils through peroxisome proliferator-activated receptor-independent mechanisms

International Archives of Allergy and Immunology

Volumn 158, Issue 4, 2012, Pages 375-386

  Tanigai, Tomomi ^a   Ueki, Shigeharu ^a   Kihara, Junko ^a   Kamada, Rie ^a   Yamauchi, Yumiko ^a   Sokal, Andrei ^a   Takeda, Masahide ^a   Ito, Wataru ^a   Kayaba, Hiroyuki ^a   Adachi, Tetsuya ^b   Ohta, Ken ^b   Chihara, Junichi ^a  

^a AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Allergy; Apoptosis; Chemotaxis; Docosahexaenoic acid; Eosinophils; Peroxisome proliferator activated receptor

Indexed keywords

CASPASE 3; CHEMOKINE RECEPTOR CCR3; DOCOSAHEXAENOIC ACID; EOTAXIN; FAS ANTIGEN; INTERLEUKIN 5; LINOLEIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CALCIUM TRANSPORT; CELL CULTURE; CELL MOTION; CELL SURVIVAL; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EOSINOPHIL; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; PREMEDICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANTIGENS, CD95; APOPTOSIS; CALCIUM; CASPASE 3; CELL MOVEMENT; CELLS, CULTURED; DOCOSAHEXAENOIC ACIDS; EOSINOPHILIA; EOSINOPHILS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; LINOLEIC ACID; MALE; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PHOSPHORYLATION; RECEPTORS, CCR3; SEVERITY OF ILLNESS INDEX;

EID: 84859402740     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000332965     Document Type: Article

References (44)

1. Daugherty BL, Siciliano SJ, DeMartino JA, Malkowitz L, Sirotina A, Springer MS: Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J Exp Med 1996; 183: 2349-2354. (Pubitemid 26158926)
2. Kita H, Weiler DA, Abu-Ghazaleh R, San-derson CJ, Gleich GJ: Release of granule proteins from eosinophils cultured with IL-5. J Immunol 1992; 149: 629-635.
3. Black PN, Sharpe S: Dietary fat and asthma: is there a connection? Eur Respir J 1997; 10: 6-12. (Pubitemid 27047172)
4. Calder PC: n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006; 83: 1505-1519.
5. Hjelmgren J, Svensson A, Jörgensen ET, Lindemalm-Lundstam B, Ragnarson Tennvall G: Cost-effectiveness of tacrolimus ointment vs. standard treatment in patients with moderate and severe atopic dermatitis: a healtheconomic model simulation based on a patient survey and clinical trial data. Br J Dermatol 2007; 156: 913-921. (Pubitemid 46642804)
6. Rangi SP, Serwonska MH, Lenahan GA, Pickett WC, Blake VA, Sample S, Goetzl EJ: Suppression by ingested eicosapentaenoic acid of the increases in nasal mucosal blood flow and eosinophilia of ryegrass-allergic reactions. J Allergy Clin Immunol 1990; 85: 484-489. (Pubitemid 20075186)
7. Zapata-Gonzalez F, Rueda F, Petriz J, Domingo P, Villarroya F, Diaz-Delfin J, de Madariaga MA, Domingo JC: Human dendritic cell activities are modulated by the omega-3 fatty acid, docosahexaenoic acid, mainly through PPAR(gamma):RXR heterodimers: comparison with other polyunsaturated fatty acids. J Leukoc Biol 2008;84: 1172-1182.
8. Tuller ER, Brock AL: PPARalpha signaling mediates the synergistic cytotoxicity of clioquinol and docosahexaenoic acid in human cancer cells. Biochem Pharmacol 2009; 77: 1480-1486.
9. Kawashima A, Harada T, Imada K, Yano T, Mizuguchi K: Eicosapentaenoic acid inhibits interleukin-6 production in interleukin-1beta-stimulated C6 glioma cells through peroxisome proliferator-activated receptorgamma. Prostaglandins Leukot Essent Fatty Acids 2008; 79: 59-65.
10. Zand H, Rahimipour A, Salimi S, Shafiee SM: Docosahexaenoic acid sensitizes Ramos cells to Gamma-irradiation-induced apoptosis through involvement of PPAR-gamma activation and NF-kappaB suppression. Mol Cell Biochem 2008; 317: 113-120.
11. Gervois P, Fruchart JC, Staels B: Inflammation, dyslipidaemia, diabetes and PPARs: pharmacological interest of dual PPARalpha and PPARgamma agonists. Int J Clin Pract Suppl 2004; 143: 22-29. (Pubitemid 39627019)
12. Krey G, Braissant O, L'Horset F, Kalkhoven E, Perroud M, Parker MG, Wahli W: Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol Endocrinol 1997; 11: 779-791. (Pubitemid 27225305)
13. Ueki S, Mahemuti G, Oyamada H, Kato H, Kihara J, Tanabe M, Ito W, Chiba T, Takeda M, Kayaba H, Chihara J: Retinoic acids are potent inhibitors of spontaneous human eosinophil apoptosis. J Immunol 2008; 181: 7689-7698.
14. Ueki S, Adachi T, Bourdeaux J, Oyamada H, Yamada Y, Hamada K, Kanda A, Kayaba H, Chihara J: Expression of PPARgamma in eosinophils and its functional role in survival and chemotaxis. Immunol Lett 2003; 86: 183-189. (Pubitemid 36324279)
15. Adachi T, Ueki S, Nagase H, Ohta K, Chihara J: Inhibition of eosinophil survival by peroxisome proliferator-activated receptor (PPAR)-agonists. J Allergy Clin Immunol 2007; 119(S1):217.
16. Woerly G, Honda K, Loyens M, Papin JP, Auwerx J, Staels B, Capron M, Dombrowicz D: Peroxisome proliferator-activated receptors alpha and gamma down-regulate allergic inflammation and eosinophil activation. J Exp Med 2003; 198: 411-421. (Pubitemid 36976052)
17. Druilhe A, Cai Z, Hailé S, Chouaib S, Pretolani M: Fas-mediated apoptosis in cultured human eosinophils. Blood 1996; 87: 2822-2830. (Pubitemid 26102232)
18. Ito W, Chiba T, Kanehiro A, Kato H, Yamaguchi K, Ueki S, Kayaba H, Chihara J: Hepatocyte growth factor attenuates eotaxin and PGD2-induced chemotaxis of human eosinophils. Allergy 2007; 62: 415-422. (Pubitemid 46398797)
19. Kobayashi Y, Ueki S, Mahemuti, Chiba T, Oyamada H, Saito N, Kanda A, Kayaba H, Chihara J: Physiological levels of 15-deoxy-Delta12,14-prostaglandin J2 prime eotaxininduced chemotaxis on human eosinophils through peroxisome proliferator-activated receptor-gamma ligation. J Immunol 2005; 175: 5744-5750. (Pubitemid 41508057)
20. Groop LC, Bonadonna RC, Simonson DC, Petrides AS, Shank M, DeFronzo RA: Effect of insulin on oxidative and nonoxidative pathways of free fatty acid metabolism in human obesity. Am J Physiol 1992; 26: 79-84.
21. Forman BM, Chen J, Evans RM: Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci USA 1997; 29: 4312-4317. (Pubitemid 27194238)
22. Nitta N, Tsuchiya T, Yamauchi A, Tamatani T, Kanegasaki S: Quantitative analysis of eosinophil chemotaxis tracked using a novel optical device-TAXIScan. J Immunol Methods 2007; 320: 155-163. (Pubitemid 46349105)
23. Ueki S, Oguma M, Usami A, Kamada Y, Kato H, Kamada R, Takeda M, Ito W, Tanigai T, Kayaba H, Chihara J: Regulation of peroxisome proliferator-activated receptor-gamma expression in human eosinophils by estradiol. Int Arch Allergy Immunol 2009; 149: 51-56.
24. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S: A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998; 391: 43-50. (Pubitemid 28079208)
25. Kampen GT, Stafford S, Adachi T, Jinquan T, Quan S, Grant JA, Skov PS, Poulsen LK, Alam R: Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases. Blood 2000; 95: 1911-1917. (Pubitemid 30151625)
26. Adachi T, Vita R, Sannohe S, Stafford S, Alam R, Kayaba H, Chihara J: The functional role of rho and rho-associated coiled-coil forming protein kinase in eotaxin signaling of eosinophils. J Immunol 2001; 167: 4609-4615. (Pubitemid 32954341)
27. Aires V, Hichami A, Filomenko R, Plé A, Rébé C, Bettaieb A, Khan NA: Docosahexaenoic acid induces increases in [Ca 2+[ i via inositol 1,4,5-triphosphate production and activates protein kinase C-gamma and-delta via phosphatidylserine binding site: implication in apoptosis in U937 cells. Mol Pharmacol 2007; 72: 1545-1556. (Pubitemid 350146091)
28. Druilhe A, Wallaert B, Tsicopoulos A, Lapa e Silva JR, Tillie-Leblond I, Tonnel AB, Pretolani M: Apoptosis, proliferation, and expression of Bcl-2, Fas, and Fas ligand in bronchial biopsies from asthmatics. Am J Respir Cell Mol Biol 1998; 19: 747-757. (Pubitemid 128353674)
29. Sweeney B, Puri P, Reen DJ: Induction and modulation of apoptosis in neonatal monocytes by polyunsaturated fatty acids. J Pediatr Surg 2007; 42: 620-628. (Pubitemid 46613803)
30. Siddiqui RA, Jenski LJ, Neff K, Harvey K, Kovacs RJ, Stillwell W: Docosahexaenoic acid induces apoptosis in Jurkat cells by a protein phosphatase-mediated process. Biochim Biophys Acta 2001; 1499: 265-275. (Pubitemid 32332770)
31. Kikuchi S, Sakamoto T, Ishikawa C, Yazawa K, Torii S: Modulation of eosinophil chemotactic activities to leukotriene B4 by n-3 polyunsaturated fatty acids. Prostaglandins Leukot Essent Fatty Acids 1998; 58: 243-248. (Pubitemid 28175115)
32. Broide D, Sriramarao P: Eosinophil trafficking to sites of allergic inflammation. Immunol Rev 2001; 179: 163-172. (Pubitemid 32171283)
33. Chiba T, Kamada Y, Saito N, Oyamada H, Ueki S, Kobayashi Y, Kayaba H, Chihara J: RANTES and eotaxin enhance CD11b and CD18 expression on eosinophils from allergic patients with eosinophilia in the application of whole blood flow cytometry analysis. Int Arch Allergy Immunol 2005; 137: 12-16. (Pubitemid 40868768)
34. Honda K, Chihara J: Eosinophil activation by eotaxin-eotaxin primes the production of reactive oxygen species from eosinophils. Allergy 1999; 54: 1262-1269. (Pubitemid 30070312)
35. Ueki S, Matsuwaki Y, Kayaba H, Oyamada H, Kanda A, Usami A, Saito N, Chihara J: Peroxisome proliferator-activated receptor gamma regulates eosinophil functions: a new therapeutic target for allergic airway inflammation. Int Arch Allergy Immunol 2004; 134: 30-36. (Pubitemid 38721124)
36. Spears M, Donnelly I, Jolly L, Brannigan M, Ito K, McSharry C, Lafferty J, Chaudhuri R, Braganza G, Bareille P, Sweeney L, Adcock IM, Barnes PJ, Wood S, Thomson NC: Bronchodilatory effect of the PPAR-gamma agonist rosiglitazone in smokers with asthma. Clin Pharmacol Ther 2009; 86: 49-45.
37. Matsuwaki Y, Ueki S, Adachi T, Oyamada H, Kamada Y, Yamaguchi K, Kanda A, Hamada K, Kayaba H, Chihara J: The synthetic PPARgamma agonist troglitazone inhibits IL-5-induced CD69 upregulation and eosinophilderived neurotoxin release from eosinophils. Pharmacology 2005; 74: 169-173. (Pubitemid 41022577)
38. Schoonjans K, Martin G, Staels B, Auwerx J: Peroxisome proliferator-activated receptors, orphans with ligands and functions. Curr Opin Lipidol 1997; 8: 159-166. (Pubitemid 27290462)
39. Wang F, Herzmark P, Weiner OD, Srinivasan S, Servant G, Bourne HR: Lipid products of PI(3)Ks maintain persistent cell polarity and directed motility in neutrophils. Nat Cell Biol 2002; 4: 513-518. (Pubitemid 34752437)
40. Yamada T, Tani Y, Nakanishi H, Taguchi R, Arita M, Arai H: Eosinophils promote resolution of acute peritonitis by producing proresolving mediators in mice. FASEB J 2011; 25: 561-568.
41. Stephens R, Eisenbarth SC, Chaplin DD: T helper type 1 cells in asthma: friend or foe? Curr Opin Allergy Clin Immunol 2002; 2: 31-37. (Pubitemid 34269868)
42. Hodge L, Salome CM, Hughes JM, Liu-Brennan D, Rimmer J, Allman M, Pang D, Armour C, Woolcock AJ: Effect of dietary intake of omega-3 and omega-6 fatty acids on severity of asthma in children. Eur Respir J 1998; 11: 361-365. (Pubitemid 28108350)
43. Mickleborough TD, Lindley MR: Diet and exercise-induced bronchoconstriction. Chest 2006; 130: 623-624.
44. Romieu I, Castro-Giner F, Kunzli N, Sunyer J: Air pollution, oxidative stress and dietary supplementation: a review. Eur Respir J 2008; 31: 179-197.